{"id":62578,"date":"2026-08-25T09:50:23","date_gmt":"2026-08-25T13:50:23","guid":{"rendered":"https:\/\/conexion23.com\/?p=62578"},"modified":"2026-08-25T09:13:06","modified_gmt":"2026-08-25T13:13:06","slug":"descubren-una-combinacion-de-farmacos-que-mejora-el-control-del-cancer-renal-avanzado","status":"publish","type":"post","link":"https:\/\/conexion23.com\/?p=62578","title":{"rendered":"Descubren una combinaci\u00f3n de f\u00e1rmacos que mejora el control del c\u00e1ncer renal avanzado"},"content":{"rendered":"<p class=\"wp-block-paragraph\" style=\"text-align: justify;\"><strong>Por: EFE<\/strong><\/p>\n<p class=\"wp-block-paragraph\" style=\"text-align: justify;\"><strong>La combinaci\u00f3n de los f\u00e1rmacos belzutifan y lenvatinib mejora el control del c\u00e1ncer renal avanzado de c\u00e9lulas claras frente a cabozantinib, terapia est\u00e1ndar utilizada en pacientes tratados previamente con inmunoterapia, seg\u00fan concluye un ensayo internacional en el que particip\u00f3 el Vall d\u2019Hebron Instituto de Oncolog\u00eda (VHIO), de Espa\u00f1a.<\/strong><\/p>\n<p class=\"wp-block-paragraph\" style=\"text-align: justify;\">Publicado en la revista\u00a0<em>The Lancet<\/em>, el ensayo cl\u00ednico de fase III LITESPARK-011 analiza a 747 pacientes con carcinoma renal avanzado de c\u00e9lulas claras cuyo tumor hab\u00eda progresado tras recibir inmunoterapia basada en inhibidores de puntos de control inmunitario.<\/p>\n<p class=\"wp-block-paragraph\" style=\"text-align: justify;\">Los participantes fueron divididos en dos grupos: 371 recibieron la combinaci\u00f3n experimental de belzutifan y lenvatinib, mientras que 376 fueron tratados con el f\u00e1rmaco est\u00e1ndar cabozantinib.<\/p>\n<p style=\"text-align: justify;\">Esta doble estrategia busca dificultar el crecimiento tumoral desde distintas v\u00edas biol\u00f3gicas al combinar el belzutifan, que inhibe la prote\u00edna HIF-2 alfa implicada en la supervivencia tumoral, con el lenvatinib, que bloquea la formaci\u00f3n de los vasos sangu\u00edneos que alimentan al tumor.<\/p>\n<p class=\"wp-block-paragraph\" style=\"text-align: justify;\">Tras un seguimiento medio de casi 29 meses, los resultados mostraron una supervivencia libre de progresi\u00f3n de 14,8 meses con la nueva combinaci\u00f3n frente a los 10,7 meses de la opci\u00f3n habitual, lo que supone una reducci\u00f3n del 30 % en el riesgo de progresi\u00f3n de la enfermedad o muerte.<\/p>\n<p class=\"wp-block-paragraph\" style=\"text-align: justify;\">\u00abLos resultados del estudio suponen un avance relevante porque muestran por primera vez una nueva combinaci\u00f3n de tratamientos que puede mejorar de forma significativa el control de la enfermedad frente a la terapia est\u00e1ndar\u00bb, destaca la coautora del trabajo Cristina Su\u00e1rez.<\/p>\n<p class=\"wp-block-paragraph\" style=\"text-align: justify;\">La investigaci\u00f3n detalla adem\u00e1s que la masa tumoral se redujo o desapareci\u00f3 en el 53 % de los pacientes tratados con la nueva terapia frente al 40 % del grupo de control, mientras que la supervivencia global mostr\u00f3 una tendencia favorable no estad\u00edsticamente significativa de 34,9 meses frente a 27,6 meses.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Por: EFE La combinaci\u00f3n de los f\u00e1rmacos belzutifan y lenvatinib mejora el control del c\u00e1ncer renal avanzado de c\u00e9lulas claras frente a cabozantinib, terapia est\u00e1ndar utilizada en pacientes tratados previamente con inmunoterapia, seg\u00fan concluye un ensayo internacional en el que particip\u00f3 el Vall d\u2019Hebron Instituto de Oncolog\u00eda (VHIO), de Espa\u00f1a. Publicado en la revista\u00a0The Lancet, [&hellip;]<\/p>\n","protected":false},"author":18,"featured_media":62579,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[24],"tags":[11442,8702,11441,11443,132],"class_list":["post-62578","post","type-post","status-publish","format-standard","has-post-thumbnail","category-salud","tag-cencer","tag-farmacos","tag-iii-litespark-011","tag-instituto-de-oncologia","tag-salud"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Descubren una combinaci\u00f3n de f\u00e1rmacos que mejora el control del c\u00e1ncer renal avanzado - Conexi\u00f3n 23<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/conexion23.com\/?p=62578\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Descubren una combinaci\u00f3n de f\u00e1rmacos que mejora el control del c\u00e1ncer renal avanzado - Conexi\u00f3n 23\" \/>\n<meta property=\"og:description\" content=\"Por: EFE La combinaci\u00f3n de los f\u00e1rmacos belzutifan y lenvatinib mejora el control del c\u00e1ncer renal avanzado de c\u00e9lulas claras frente a cabozantinib, terapia est\u00e1ndar utilizada en pacientes tratados previamente con inmunoterapia, seg\u00fan concluye un ensayo internacional en el que particip\u00f3 el Vall d\u2019Hebron Instituto de Oncolog\u00eda (VHIO), de Espa\u00f1a. Publicado en la revista\u00a0The Lancet, [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/conexion23.com\/?p=62578\" \/>\n<meta property=\"og:site_name\" content=\"Conexi\u00f3n 23\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/conexion23com\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-25T13:50:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/conexion23.com\/wp-content\/uploads\/2026\/08\/Descubren-una-combinacion-de-farmacos-que-mejora-el-control-del-cancer-renal-avanzado.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1366\" \/>\n\t<meta property=\"og:image:height\" content=\"768\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Redacci\u00f3n\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Redacci\u00f3n\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/conexion23.com\\\/?p=62578#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/conexion23.com\\\/?p=62578\"},\"author\":{\"name\":\"Redacci\u00f3n\",\"@id\":\"https:\\\/\\\/conexion23.com\\\/#\\\/schema\\\/person\\\/0a860802b17d01ad2a278f53c507c296\"},\"headline\":\"Descubren una combinaci\u00f3n de f\u00e1rmacos que mejora el control del c\u00e1ncer renal avanzado\",\"datePublished\":\"2026-08-25T13:50:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/conexion23.com\\\/?p=62578\"},\"wordCount\":332,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/conexion23.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/conexion23.com\\\/?p=62578#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/conexion23.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/Descubren-una-combinacion-de-farmacos-que-mejora-el-control-del-cancer-renal-avanzado.webp\",\"keywords\":[\"cencer\",\"f\u00e1rmacos\",\"III LITESPARK-011\",\"Instituto de Oncolog\u00eda\",\"SALUD\"],\"articleSection\":[\"Salud\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/conexion23.com\\\/?p=62578#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/conexion23.com\\\/?p=62578\",\"url\":\"https:\\\/\\\/conexion23.com\\\/?p=62578\",\"name\":\"Descubren una combinaci\u00f3n de f\u00e1rmacos que mejora el control del c\u00e1ncer renal avanzado - Conexi\u00f3n 23\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/conexion23.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/conexion23.com\\\/?p=62578#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/conexion23.com\\\/?p=62578#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/conexion23.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/Descubren-una-combinacion-de-farmacos-que-mejora-el-control-del-cancer-renal-avanzado.webp\",\"datePublished\":\"2026-08-25T13:50:23+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/conexion23.com\\\/?p=62578#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/conexion23.com\\\/?p=62578\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/conexion23.com\\\/?p=62578#primaryimage\",\"url\":\"https:\\\/\\\/conexion23.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/Descubren-una-combinacion-de-farmacos-que-mejora-el-control-del-cancer-renal-avanzado.webp\",\"contentUrl\":\"https:\\\/\\\/conexion23.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/Descubren-una-combinacion-de-farmacos-que-mejora-el-control-del-cancer-renal-avanzado.webp\",\"width\":1366,\"height\":768},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/conexion23.com\\\/?p=62578#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/conexion23.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Descubren una combinaci\u00f3n de f\u00e1rmacos que mejora el control del c\u00e1ncer renal avanzado\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/conexion23.com\\\/#website\",\"url\":\"https:\\\/\\\/conexion23.com\\\/\",\"name\":\"Conexi\u00f3n 23\",\"description\":\"Peri\u00f3dico 100% Petromacorisano\",\"publisher\":{\"@id\":\"https:\\\/\\\/conexion23.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/conexion23.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/conexion23.com\\\/#organization\",\"name\":\"Conexion 23\",\"url\":\"https:\\\/\\\/conexion23.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/conexion23.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/conexion23.com\\\/wp-content\\\/uploads\\\/2021\\\/11\\\/Diseno-sin-titulo-2.png\",\"contentUrl\":\"https:\\\/\\\/conexion23.com\\\/wp-content\\\/uploads\\\/2021\\\/11\\\/Diseno-sin-titulo-2.png\",\"width\":541,\"height\":90,\"caption\":\"Conexion 23\"},\"image\":{\"@id\":\"https:\\\/\\\/conexion23.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/conexion23com\",\"https:\\\/\\\/www.instagram.com\\\/conexion23com\\\/\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCYc7vxxFZMYLIHNsHHxPZ3Q\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/conexion23.com\\\/#\\\/schema\\\/person\\\/0a860802b17d01ad2a278f53c507c296\",\"name\":\"Redacci\u00f3n\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ec9d84b79c776aa1994e5893944465db9974b17b884155623da51b7b62c02845?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ec9d84b79c776aa1994e5893944465db9974b17b884155623da51b7b62c02845?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ec9d84b79c776aa1994e5893944465db9974b17b884155623da51b7b62c02845?s=96&d=mm&r=g\",\"caption\":\"Redacci\u00f3n\"},\"url\":\"https:\\\/\\\/conexion23.com\\\/?author=18\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Descubren una combinaci\u00f3n de f\u00e1rmacos que mejora el control del c\u00e1ncer renal avanzado - Conexi\u00f3n 23","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/conexion23.com\/?p=62578","og_locale":"es_ES","og_type":"article","og_title":"Descubren una combinaci\u00f3n de f\u00e1rmacos que mejora el control del c\u00e1ncer renal avanzado - Conexi\u00f3n 23","og_description":"Por: EFE La combinaci\u00f3n de los f\u00e1rmacos belzutifan y lenvatinib mejora el control del c\u00e1ncer renal avanzado de c\u00e9lulas claras frente a cabozantinib, terapia est\u00e1ndar utilizada en pacientes tratados previamente con inmunoterapia, seg\u00fan concluye un ensayo internacional en el que particip\u00f3 el Vall d\u2019Hebron Instituto de Oncolog\u00eda (VHIO), de Espa\u00f1a. Publicado en la revista\u00a0The Lancet, [&hellip;]","og_url":"https:\/\/conexion23.com\/?p=62578","og_site_name":"Conexi\u00f3n 23","article_publisher":"https:\/\/www.facebook.com\/conexion23com","article_published_time":"2026-08-25T13:50:23+00:00","og_image":[{"width":1366,"height":768,"url":"https:\/\/conexion23.com\/wp-content\/uploads\/2026\/08\/Descubren-una-combinacion-de-farmacos-que-mejora-el-control-del-cancer-renal-avanzado.webp","type":"image\/webp"}],"author":"Redacci\u00f3n","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Redacci\u00f3n","Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/conexion23.com\/?p=62578#article","isPartOf":{"@id":"https:\/\/conexion23.com\/?p=62578"},"author":{"name":"Redacci\u00f3n","@id":"https:\/\/conexion23.com\/#\/schema\/person\/0a860802b17d01ad2a278f53c507c296"},"headline":"Descubren una combinaci\u00f3n de f\u00e1rmacos que mejora el control del c\u00e1ncer renal avanzado","datePublished":"2026-08-25T13:50:23+00:00","mainEntityOfPage":{"@id":"https:\/\/conexion23.com\/?p=62578"},"wordCount":332,"commentCount":0,"publisher":{"@id":"https:\/\/conexion23.com\/#organization"},"image":{"@id":"https:\/\/conexion23.com\/?p=62578#primaryimage"},"thumbnailUrl":"https:\/\/conexion23.com\/wp-content\/uploads\/2026\/08\/Descubren-una-combinacion-de-farmacos-que-mejora-el-control-del-cancer-renal-avanzado.webp","keywords":["cencer","f\u00e1rmacos","III LITESPARK-011","Instituto de Oncolog\u00eda","SALUD"],"articleSection":["Salud"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/conexion23.com\/?p=62578#respond"]}]},{"@type":"WebPage","@id":"https:\/\/conexion23.com\/?p=62578","url":"https:\/\/conexion23.com\/?p=62578","name":"Descubren una combinaci\u00f3n de f\u00e1rmacos que mejora el control del c\u00e1ncer renal avanzado - Conexi\u00f3n 23","isPartOf":{"@id":"https:\/\/conexion23.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/conexion23.com\/?p=62578#primaryimage"},"image":{"@id":"https:\/\/conexion23.com\/?p=62578#primaryimage"},"thumbnailUrl":"https:\/\/conexion23.com\/wp-content\/uploads\/2026\/08\/Descubren-una-combinacion-de-farmacos-que-mejora-el-control-del-cancer-renal-avanzado.webp","datePublished":"2026-08-25T13:50:23+00:00","breadcrumb":{"@id":"https:\/\/conexion23.com\/?p=62578#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/conexion23.com\/?p=62578"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/conexion23.com\/?p=62578#primaryimage","url":"https:\/\/conexion23.com\/wp-content\/uploads\/2026\/08\/Descubren-una-combinacion-de-farmacos-que-mejora-el-control-del-cancer-renal-avanzado.webp","contentUrl":"https:\/\/conexion23.com\/wp-content\/uploads\/2026\/08\/Descubren-una-combinacion-de-farmacos-que-mejora-el-control-del-cancer-renal-avanzado.webp","width":1366,"height":768},{"@type":"BreadcrumbList","@id":"https:\/\/conexion23.com\/?p=62578#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/conexion23.com\/"},{"@type":"ListItem","position":2,"name":"Descubren una combinaci\u00f3n de f\u00e1rmacos que mejora el control del c\u00e1ncer renal avanzado"}]},{"@type":"WebSite","@id":"https:\/\/conexion23.com\/#website","url":"https:\/\/conexion23.com\/","name":"Conexi\u00f3n 23","description":"Peri\u00f3dico 100% Petromacorisano","publisher":{"@id":"https:\/\/conexion23.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/conexion23.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/conexion23.com\/#organization","name":"Conexion 23","url":"https:\/\/conexion23.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/conexion23.com\/#\/schema\/logo\/image\/","url":"https:\/\/conexion23.com\/wp-content\/uploads\/2021\/11\/Diseno-sin-titulo-2.png","contentUrl":"https:\/\/conexion23.com\/wp-content\/uploads\/2021\/11\/Diseno-sin-titulo-2.png","width":541,"height":90,"caption":"Conexion 23"},"image":{"@id":"https:\/\/conexion23.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/conexion23com","https:\/\/www.instagram.com\/conexion23com\/","https:\/\/www.youtube.com\/channel\/UCYc7vxxFZMYLIHNsHHxPZ3Q"]},{"@type":"Person","@id":"https:\/\/conexion23.com\/#\/schema\/person\/0a860802b17d01ad2a278f53c507c296","name":"Redacci\u00f3n","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/ec9d84b79c776aa1994e5893944465db9974b17b884155623da51b7b62c02845?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/ec9d84b79c776aa1994e5893944465db9974b17b884155623da51b7b62c02845?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ec9d84b79c776aa1994e5893944465db9974b17b884155623da51b7b62c02845?s=96&d=mm&r=g","caption":"Redacci\u00f3n"},"url":"https:\/\/conexion23.com\/?author=18"}]}},"_links":{"self":[{"href":"https:\/\/conexion23.com\/index.php?rest_route=\/wp\/v2\/posts\/62578","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/conexion23.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/conexion23.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/conexion23.com\/index.php?rest_route=\/wp\/v2\/users\/18"}],"replies":[{"embeddable":true,"href":"https:\/\/conexion23.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=62578"}],"version-history":[{"count":1,"href":"https:\/\/conexion23.com\/index.php?rest_route=\/wp\/v2\/posts\/62578\/revisions"}],"predecessor-version":[{"id":62580,"href":"https:\/\/conexion23.com\/index.php?rest_route=\/wp\/v2\/posts\/62578\/revisions\/62580"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/conexion23.com\/index.php?rest_route=\/wp\/v2\/media\/62579"}],"wp:attachment":[{"href":"https:\/\/conexion23.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=62578"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/conexion23.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=62578"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/conexion23.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=62578"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}